A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Issue: Jan/Feb 2018 - Volume 22, Number 1
View All Articles in Issue
Page(s): 58
Download in electronic PDF format for $65
Abstract: A formulation for preparing Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, thalidomide, sedative hypnotic agent, antineoplastic agent, immunosuppressant, adverse effects
Related Categories: CANCER AND AIDS, EXCIPIENTS, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, NEUROLOGY